CJC-1295 (No DAC), Ipamorelin, GHRP-2 (Blend)
CJC-1295 (No DAC), Ipamorelin, GHRP-2 (Blend) Original price was: €83.28.Current price is: €70.13.
Back to products

CJC-1295 no DAC 2mg (Mod GRF 1-29)

€30.68

CJC-1295 No DAC 2mg (Mod GRF 1-29) is the short-acting 30-amino-acid modified GHRH analogue, the small-vial format suited to short-duration cell-culture experiments. Greater than 99 percent HPLC verified for in-vitro pituitary research only.

100 in stock

Description

Buy CJC-1295 no DAC 2mg (Mod GRF 1-29) – Peptide Science

CJC-1295 No DAC 2mg (Mod GRF 1-29) Overview

CJC-1295 No DAC 2mg from Peptide Science is the short-acting 30-amino-acid modified GHRH analogue (also known as Mod GRF 1-29), supplied as a lyophilised vial for in-vitro and preclinical pituitary research. The 2 mg pack is the smallest single-vial format in the modified-GHRH range, suited to short-duration cell-culture experiments where a small working stock matches the assay schedule.

## Compound Class and Mechanism

CJC-1295 No DAC (also designated Mod GRF 1-29) is the short-acting form of the modified GHRH analogue, distinct from the long-acting DAC-conjugated variant. The 30-amino-acid sequence is based on GHRH 1-29 with four targeted substitutions (D-Ala at position 2, Gln at position 8, Ala at position 15, and Leu at position 27) that improve enzymatic stability and receptor affinity without adding the maleimidopropionic-acid Drug Affinity Complex. The short-acting form is preferred in preclinical research protocols where pulsatile rather than continuous receptor activation is the study target. Browse related compounds in the growth-hormone peptide range.

## Vial Specifications

| Property | Value |
| — | — |
| Compound | CJC-1295 No DAC (Mod GRF 1-29) |
| Class | Modified GHRH analogue, short-acting (no Drug Affinity Complex) |
| Amino-acid count | 30 |
| Molecular weight | approximately 3367 g/mol |
| Supplied form | Lyophilised powder, sealed vial |
| Strength | 2 mg per vial |
| Purity | greater than 99 percent (HPLC and mass-spec verified) |
| Storage | 2 to 8 degrees Celsius lyophilised; minus 20 degrees Celsius long-term |

For the larger 5 mg vial of the same modified-GHRH analogue, see CJC-1295 No DAC 5mg (Mod GRF 1-29).

## Reconstitution and Handling

The lyophilised vial reconstitutes with bacteriostatic water at the working concentration set by the principal investigator. Aliquoting reconstituted stock for single-use frozen storage is the standard preclinical handling practice cited in pituitary-research literature, since repeated freeze-thaw cycles degrade short-sequence peptides.

## Quality and Shipping

Each batch passes HPLC at greater than 99 percent purity, with mass-spectrometry identity confirmation against the theoretical molecular weight. A Certificate of Analysis accompanies every order. Material is filled in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in temperature-monitored insulated packaging via overnight or two-day courier.

For laboratory research and development use only. Not for human or veterinary consumption. Has not been evaluated by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Purchasers acknowledge they are qualified researchers age 21 or older and accept responsibility for compliance with all applicable federal, state, and local laws. Lyophilised vials store at 2 to 8 degrees Celsius; protect from light.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 no DAC 2mg (Mod GRF 1-29)”